✦ LIBER ✦

Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis

✍ Scribed by Toshiaki Kinouchi; Junichi Sakamoto; Taiji Tsukamoto; Hideyuki Akaza; Yoshinobu Kubota; Seiichiro Ozono; Hiroshi Kanetake; Tetsuo Taguchi; Toshihiko Kotake; Immunotherapy Oncology Group for Renal Cell Carcinoma

Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 213 KB
Volume: 132
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-006-0095-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of interferon alpha-2A

A phase II trial of interferon alpha-2A plus fluorouracil in advanced renal cell carcinoma

✍ Brian R. Murphy; Susan M. Rynard; Lawrence H. Einhorn; Patrick J. Loehrer 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 499 KB

Upfront, randomized, phase 2 trial of so

Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma : Clinical and biomarker analysis

✍ Eric Jonasch; Paul Corn; Lance C. Pagliaro; Carla L. Warneke; Marcella M. Johnso 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract ## BACKGROUND: The objective of this study was to independently evaluate the objective response rate of sorafenib and sorafenib plus low‐dose interferon‐alfa 2b (IFN) as frontline therapy in patients with metastatic renal cell carcinoma (mRCC). ## METHODS: Untreated patients with cle